A phase III, multi-center, randomized, double-blind, placebo-controlled, parallel group trial of 14 day treatment with lansoprazole 15 mg once a day in frequent heartburn

Trial Profile

A phase III, multi-center, randomized, double-blind, placebo-controlled, parallel group trial of 14 day treatment with lansoprazole 15 mg once a day in frequent heartburn

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jul 2009

At a glance

  • Drugs Lansoprazole (Primary)
  • Indications Heartburn
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 01 Jul 2009 Primary endpoint 'Symptom free days' has been met.
    • 01 Jul 2009 Results have been reported in Postgraduate Medicine.
    • 12 Jan 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top